Profiling heparan sulfate proteoglycans in ovarian carcinoma.
Clamp
Andrew R
AR
Cancer Research UK Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Withington, Manchester, M20 4BX, UK. aclamp@picr.man.ac.uk
Jayson
Gordon C
GC
D002277:Carcinoma / Q000175:diagnosis / Q000378:metabolism*; D005260:Female; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism*; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D011379:Prognosis; D011509:Proteoglycans / Q000378:metabolism; D053667:Syndecans
D019812:Heparan Sulfate Proteoglycans; D008562:Membrane Glycoproteins; D011509:Proteoglycans; D053667:Syndecans; C071927:perlecan